Skip to NavigationSkip to content

Pharmafile - Business Services

Novartis announces cut to multiple drug research programmes in 2022 full-year report
Novartis, a Swiss pharmaceutical company, has announced in its 2022 full-year report that it is cutting several of their programmes, including their...
Sherlock Biosciences acquires Sense Biodetection to advance CRISPR-based diagnostics
US-based biotech company Sherlock Biosciences has acquired UK-based developer of rapid molecular diagnostics Sense Biodetection.
Chiesi Farmaceutici hires new CEO after $1.48bn Amryst acquisition
Chiesi Farmaceutici, a family-owned Italian pharmaceutical company, has appointed Giuseppe Accogli as group CEO. This comes after 2020’s $1.48bn...
Merck’s London research hub to begin construction in April 2023
Merck has been planning a $1.3bn, 220,000 square foot research hub in London for six years but will finally begin construction in April this year,...
>> More Business Services News Stories

Features

Outsourcing in clinical trials: A response to rising challenges

Clinical trials are complex, multifaceted projects, and this makes them infamously expensive to run, but outsourcing to contract research...

>> More Features

Appointments

Germo Gericke, MD
  • Dr. Gericke brings extensive experience in the research and development of radioligand therapies
  • Appointment...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches